SM(d18:0/22:1(13Z))
|
Basic information |
| Metabolite name | SM(d18:0/22:1(13Z)) |
 | HMDB0012092 |
 |
C00550 |
 |
53481362 |
| Synonyms | N-(13Z-Docosenoyl)-sphinganine-1-phosphocholine |
| No. of studies | 2 |
|
Basic information |
| Metabolite name | SM(d18:0/22:1(13Z)) |
| HMDB0012092 |
|
C00550 |
|
53481362 |
| Synonyms | N-(13Z-Docosenoyl)-sphinganine-1-phosphocholine |
| No. of studies | 2 |
|
Relationship between SM(d18:0/22:1(13Z)) and depression (count: 2) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M774 | Type1 | MDD group vs. control group | Serum | Human | Up |
| Study M918 | Type1 | methamphetamine group vs. control group | Serum | C57BL/6 mouse | Up |